ViewMind Joins Bio-Hermes-002 Landmark Study
1 known investors
Global Alzheimer's Platform (GAP) operates GAP-Net, a network of over 100 clinical research sites across North America and Europe, to speed up clinical trials for Alzheimer's and Parkinson's disease treatments. It provides services such as GAP Participant Services (GPS Liaisons) and an Inclusive Research Initiative (Community Connectors) aimed at promoting diversity and lowering the cost and duration of neurodegenerative disease trials.
BiotechHealthtechImpact & Social Good
Investors · 1
Frequently asked questions
- What does ViewMind Joins Bio-Hermes-002 Landmark Study do?
- Global Alzheimer's Platform (GAP) operates GAP-Net, a network of over 100 clinical research sites across North America and Europe, to speed up clinical trials for Alzheimer's and Parkinson's disease treatments. It provides services such as GAP Participant Services (GPS Liaisons) and an Inclusive Research Initiative (Community Connectors) aimed at promoting diversity and lowering the cost and duration of neurodegenerative disease trials.
- Who are ViewMind Joins Bio-Hermes-002 Landmark Study's investors?
- ViewMind Joins Bio-Hermes-002 Landmark Study's investors include Wealthing VC Club.